[go: up one dir, main page]

TWI856228B - Separation base, cell separation filter, and method of preparing platelet - Google Patents

Separation base, cell separation filter, and method of preparing platelet Download PDF

Info

Publication number
TWI856228B
TWI856228B TW110100191A TW110100191A TWI856228B TW I856228 B TWI856228 B TW I856228B TW 110100191 A TW110100191 A TW 110100191A TW 110100191 A TW110100191 A TW 110100191A TW I856228 B TWI856228 B TW I856228B
Authority
TW
Taiwan
Prior art keywords
separation substrate
coarse filter
separation
membranes
membrane
Prior art date
Application number
TW110100191A
Other languages
Chinese (zh)
Other versions
TW202130802A (en
Inventor
神長邦行
竹上竜太
武井俊樹
山田忠範
中川洋亮
金村一秀
Original Assignee
日商富士軟片股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商富士軟片股份有限公司 filed Critical 日商富士軟片股份有限公司
Publication of TW202130802A publication Critical patent/TW202130802A/en
Application granted granted Critical
Publication of TWI856228B publication Critical patent/TWI856228B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/12Apparatus for enzymology or microbiology with sterilisation, filtration or dialysis means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/06Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Medicinal Chemistry (AREA)
  • Water Supply & Treatment (AREA)
  • Virology (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本發明的課題在於提供一種巨核細胞的去除率及血小板的回收率均高並且過濾壽命長的分離基材以及使用了該分離基材之細胞分離過濾器及血小板之製造方法。本發明的分離基材由用於從包含巨核細胞及血小板之細胞懸浮液分離血小板之多孔體構成,前述分離基材中,分離基材具有從細胞懸浮液的流入側依序配置有粗過濾層及精密過濾層之區域,粗過濾層包含1片以上的粗過濾膜,精密過濾層包含1片以上的精密過濾膜,粗過濾膜中的至少1片為平均孔徑成為5.0μm以上且30.0μm以下並且細孔直徑分布的峰值成為小於30%之粗過濾膜X,精密過濾膜中的至少1片為平均孔徑成為2.0μm以上且20.0μm以下並且細孔直徑分布的峰值成為30%以上之精密過濾膜Y。The subject of the present invention is to provide a separation substrate with high megakaryocyte removal rate and platelet recovery rate and long filtration life, as well as a cell separation filter and platelet manufacturing method using the separation substrate. The separation substrate of the present invention is composed of a porous body used to separate platelets from a cell suspension containing megakaryocytes and platelets. In the aforementioned separation substrate, the separation substrate has a region in which a coarse filter layer and a fine filter layer are sequentially arranged from the inflow side of the cell suspension, the coarse filter layer includes one or more coarse filter membranes, and the fine filter layer includes one or more fine filter membranes. At least one of the coarse filter membranes is a coarse filter membrane X having an average pore size of 5.0 μm or more and 30.0 μm or less and a peak value of the pore diameter distribution of less than 30%, and at least one of the fine filter membranes is a fine filter membrane Y having an average pore size of 2.0 μm or more and 20.0 μm or less and a peak value of the pore diameter distribution of more than 30%.

Description

分離基材、細胞分離過濾器及血小板之製造方法Separation substrate, cell separation filter, and platelet manufacturing method

本發明涉及一種分離基材、細胞分離過濾器及血小板之製造方法。The present invention relates to a separation substrate, a cell separation filter and a method for manufacturing platelets.

血小板係在血栓的形成中發揮主導作用且在活體內顯現止血功能之細胞,因此若出血時或使用抗癌劑時血小板減少,則嚴重的情況下有時導致死亡。 而且,對血小板的減少之唯一的確定治療法係輸注血小板製劑。目前的血小板製劑依賴於來自志願者的獻血,儘管保存有效期間為4天之極短的天數,但隨著因少子化而能夠獻血的年齡層的人口減少及血液製劑血的需求高之高齡人的人口增加,預測醫療現場中的需求與供給的平衡難以保持。 因此,代替獻血之血小板來源的開發備受關注。Platelets are cells that play a leading role in the formation of blood clots and exhibit hemostatic functions in the living body. Therefore, if platelets are reduced during bleeding or when using anticancer drugs, it may lead to death in severe cases. In addition, the only definite treatment for platelet reduction is transfusion of platelet products. Current platelet products rely on blood donations from volunteers. Although the shelf life is a very short 4 days, it is expected that it will be difficult to maintain a balance between demand and supply in the medical field as the population of the age group that can donate blood decreases due to the declining birth rate and the population of the elderly with high demand for blood products increases. Therefore, the development of platelet sources that replace blood donations has attracted much attention.

近年來,已報導了藉由將多能性乾細胞、造血祖細胞、間充質細胞等作為來源培養巨核細胞來在體外大量生產血小板之技術。 在該技術中,血小板藉由巨核細胞的細胞質被切割而產生,因此在血小板生產後的培養液中含有大量的巨核細胞。 因此,從抑制免疫原性之觀點考慮,需要開發分離巨核細胞及從巨核細胞生產之血小板之技術。In recent years, a technique for producing a large number of platelets in vitro by culturing megakaryocytes using pluripotent stem cells, hematopoietic progenitor cells, mesenchymal cells, etc. as sources has been reported. In this technique, platelets are produced by cleavage of the cytoplasm of megakaryocytes, so a large number of megakaryocytes are contained in the culture medium after platelet production. Therefore, from the perspective of suppressing immunogenicity, it is necessary to develop a technique for isolating megakaryocytes and producing platelets from megakaryocytes.

作為這樣的分離技術,例如在專利文獻1中記載有:“一種分離基材,其由用於從包含巨核細胞及血小板之細胞懸浮液分離血小板之不織布構成,前述分離基材中,前述分離基材的平均孔徑為2.0μm以上且15.0μm以下,前述分離基材的厚度為10μm以上且500μm以下。”([請求項1])。As such a separation technology, for example, Patent Document 1 describes: "A separation substrate, which is composed of a non-woven fabric for separating platelets from a cell suspension containing megakaryocytes and platelets, wherein the average pore size of the separation substrate is greater than 2.0 μm and less than 15.0 μm, and the thickness of the separation substrate is greater than 10 μm and less than 500 μm." ([Claim 1]).

[專利文獻1]國際公開第2018/207564號[Patent Document 1] International Publication No. 2018/207564

本發明人等對專利文獻1中所記載之分離基材進行了研究,其結果得知巨核細胞的去除率(阻止率)高且血小板的回收率(透過率)高,但是明確了對過濾壽命存在改善的空間。The inventors of the present invention have studied the separation substrate described in Patent Document 1 and found that the removal rate (blocking rate) of megakaryocytes is high and the recovery rate (permeability) of platelets is high, but it has been found that there is room for improvement in the filtration life.

因此,本發明的課題在於提供一種巨核細胞的去除率及血小板的回收率均高並且過濾壽命長的分離基材以及使用了該分離基材之細胞分離過濾器及血小板之製造方法。Therefore, the subject of the present invention is to provide a separation substrate with high megakaryocyte removal rate and platelet recovery rate and long filtration life, as well as a cell separation filter and platelet manufacturing method using the separation substrate.

本發明人等為了實現上述課題進行了深入研究之結果,發現了如下而完成了本發明:在分離基材中,從細胞懸浮液的流入側設置依序配置有粗過濾層及精密過濾層之區域,藉此巨核細胞的去除率及血小板的回收率均高並且過濾壽命變長,前述粗過濾層包含滿足既定參數之粗過濾膜,前述精密過濾層包含滿足既定參數之精密過濾膜。 亦即,本發明人等發現了藉由以下的構成能夠實現上述課題。As a result of in-depth research to achieve the above-mentioned topic, the inventors of the present invention have completed the present invention by discovering the following: in the separation substrate, a region in which a coarse filter layer and a fine filter layer are sequentially arranged from the inflow side of the cell suspension, thereby increasing the removal rate of megakaryocytes and the recovery rate of platelets and prolonging the filtration life, and the coarse filter layer includes a coarse filter membrane that meets predetermined parameters, and the fine filter layer includes a fine filter membrane that meets predetermined parameters. That is, the inventors of the present invention have discovered that the above-mentioned topic can be achieved by the following structure.

[1]一種分離基材,其係由用於從包含巨核細胞及血小板之細胞懸浮液分離血小板之多孔體構成,前述分離基材中, 分離基材具有從細胞懸浮液的流入側依序配置有粗過濾層及精密過濾層之區域, 粗過濾層包含1片以上的粗過濾膜, 精密過濾層包含1片以上的精密過濾膜, 粗過濾膜中的至少1片為藉由半乾法測量之平均孔徑成為5.0μm以上且30.0μm以下並且細孔直徑分布的峰值成為小於30%之粗過濾膜X, 精密過濾膜中的至少1片為藉由半乾法測量之平均孔徑成為2.0μm以上且20.0μm以下並且細孔直徑分布的峰值成為30%以上之精密過濾膜Y。[1] A separation substrate, which is composed of a porous body for separating platelets from a cell suspension containing megakaryocytes and platelets, wherein the separation substrate has a region in which a coarse filter layer and a fine filter layer are arranged in order from the inflow side of the cell suspension, the coarse filter layer includes one or more coarse filter membranes, the fine filter layer includes one or more fine filter membranes, and the coarse filter membrane includes one or more fine filter membranes. At least one of the coarse filter membranes is a coarse filter membrane X having an average pore size of 5.0 μm or more and 30.0 μm or less as measured by a semi-dry method and a peak value of the pore diameter distribution of less than 30%, and at least one of the fine filter membranes is a fine filter membrane Y having an average pore size of 2.0 μm or more and 20.0 μm or less as measured by a semi-dry method and a peak value of the pore diameter distribution of more than 30%.

[2]如[1]所述之分離基材,其中 粗過濾膜X為滿足下述式(1)之膜。 150≤平均孔徑(μm)的數值×厚度(μm)的數值≤1500 (1) [3]如[1]或[2]所述之分離基材,其中 精密過濾膜Y的孔隙率為40%以上且90%以下。 [4]如[1]至[3]之任一項所述之分離基材,其中 粗過濾膜X的孔隙率為40%以上且90%以下。 [5]如[1]至[4]之任一項所述之分離基材,其中 粗過濾層包含3片以上的粗過濾膜。 [6]如[1]至[5]之任一項所述之分離基材,其中 粗過濾層中所包含之所有粗過濾膜及精密過濾層中所包含之所有精密過濾膜為臨界潤濕表面張力為72mN/m以上的膜。[2] A separation substrate as described in [1], wherein the coarse filter membrane X is a membrane satisfying the following formula (1). 150 ≤ the value of the average pore size (μm) × the value of the thickness (μm) ≤ 1500 (1) [3] A separation substrate as described in [1] or [2], wherein the porosity of the fine filter membrane Y is greater than 40% and less than 90%. [4] A separation substrate as described in any one of [1] to [3], wherein the porosity of the coarse filter membrane X is greater than 40% and less than 90%. [5] A separation substrate as described in any one of [1] to [4], wherein the coarse filter layer comprises more than 3 coarse filter membranes. [6] A separation substrate as described in any one of [1] to [5], wherein all the coarse filter membranes contained in the coarse filter layer and all the fine filter membranes contained in the fine filter layer are membranes having a critical wetting surface tension of 72 mN/m or more.

[7]如[1]至[6]之任一項所述之分離基材,其中 多孔體為不織布。 [8]如[7]所述之分離基材,其中 不織布包含選自包括纖維素樹脂及聚烯烴樹脂之群組中之至少1種樹脂。 [9]如[8]所述之分離基材,其中 纖維素樹脂為纖維素醯化物或纖維素。 [10]如[8]所述之分離基材,其中 聚烯烴樹脂為聚丙烯。 [11]如[10]所述之分離基材,其中 聚丙烯為經親水化處理之聚丙烯。[7] A separation substrate as described in any one of [1] to [6], wherein the porous body is a nonwoven fabric. [8] A separation substrate as described in [7], wherein the nonwoven fabric comprises at least one resin selected from the group consisting of a cellulose resin and a polyolefin resin. [9] A separation substrate as described in [8], wherein the cellulose resin is a cellulose acylate or cellulose. [10] A separation substrate as described in [8], wherein the polyolefin resin is polypropylene. [11] A separation substrate as described in [10], wherein the polypropylene is hydrophilized polypropylene.

[12]一種細胞分離過濾器,其係具備配置有第1通液口及第2通液口之容器及填充於第1通液口與第2通液口之間之濾材,前述分離過濾器中, 濾材為[1]至[11]之任一項所述之分離基材。 [13]一種血小板之製造方法,其係包括: 使至少包含巨核細胞之培養液與[1]至[11]之任一項所述之分離基材接觸之步驟; 培養步驟,在接觸步驟之前及之後的至少一方中,培養巨核細胞而產生血小板;及 回收步驟,在接觸步驟及培養步驟之後,回收包含所產生之血小板之培養液。 [發明效果][12] A cell separation filter comprising a container having a first liquid port and a second liquid port and a filter material filled between the first liquid port and the second liquid port, wherein the filter material is a separation substrate as described in any one of [1] to [11]. [13] A method for producing platelets, comprising: a step of bringing a culture medium containing at least megakaryocytes into contact with a separation substrate as described in any one of [1] to [11]; a culturing step of culturing megakaryocytes to produce platelets at least one of before and after the contacting step; and a recovery step of recovering the culture medium containing the produced platelets after the contacting step and the culturing step. [Effect of the invention]

依據本發明,本發明能提供一種巨核細胞的去除率及血小板的回收率均高並且過濾壽命長的分離基材以及使用了該分離基材之細胞分離過濾器及血小板之製造方法。According to the present invention, a separation substrate having high megakaryocyte removal rate and platelet recovery rate and long filtration life, as well as a cell separation filter and platelet manufacturing method using the separation substrate can be provided.

以下,對本發明進行了詳細的說明。 以下所記載之構成要件的說明係根據本發明的代表性的實施態樣而完成者,但是本發明並不限定於該種實施態樣。 另外,在本說明書中,用“~”來表示之數值範圍係指將記載於“~”前後之數值作為下限值及上限值而包括之範圍。 又,本說明書中,各成分可以使用單獨1種相當於各成分之物質,亦可以併用2種以上。在此,針對各成分併用2種以上的物質之情況下,除非另有說明,否則其成分的含量係指所併用之物質的合計的含量。The present invention is described in detail below. The description of the constituent elements described below is completed based on the representative implementation of the present invention, but the present invention is not limited to the implementation. In addition, in this specification, the numerical range represented by "~" refers to the range that includes the numerical values recorded before and after "~" as the lower limit and upper limit. In addition, in this specification, each component can use a single substance equivalent to each component, or two or more substances can be used in combination. Here, for each component using two or more substances in combination, unless otherwise specified, the content of the component refers to the total content of the substances used in combination.

通常,分離基材係指在內部具有大量小孔隙之結構體,例如可舉出纖維結構體、多孔膜、滾珠填充管柱及由該等積層體構成者。 其中,纖維結構體係指纏結纖維而成為一個結構者,例如可舉出織物(網狀物(mesh))、編物、編織繩、不織布及將纖維填充到管柱中者等,其中,從寬的孔徑分布、複雜的流路、製作容易性的方面考慮,尤其不織布為較佳。又,作為不織布的製法,例如可舉出乾式法、濕式法、紡黏法、熔噴法、靜電紡絲法、針刺法等,其中,從生產性及通用性的方面考慮,濕式法及熔噴法、靜電紡絲法為較佳。 多孔膜係指在整個塑膠體具有無數連通孔者,作為製法可舉出相分離法、發泡法、照射放射線或雷射光等之蝕刻法、成孔法、冷凍乾燥法、塑膠燒結法等,但是從複雜的流路、製作容易性的方面考慮,尤其使用了相分離法之多孔膜為較佳。 滾珠填充管柱係指藉由在管柱內填充滾珠而在滾珠之間形成孔隙者。期望滾珠的粒徑為均勻者,藉由滾珠的粒徑而容易控制滾珠之間的孔隙作為孔徑。Generally, a separation substrate refers to a structure having a large number of small pores inside, such as a fiber structure, a porous membrane, a bead-filled column, and a laminate composed of the above. Among them, a fiber structure refers to a structure formed by entangled fibers, such as a woven fabric (mesh), a knitted fabric, a braided rope, a non-woven fabric, and a column filled with fibers, etc. Among them, non-woven fabrics are particularly preferred in terms of wide pore size distribution, complex flow paths, and ease of production. In addition, as a method for making nonwoven fabrics, for example, dry method, wet method, spunbond method, melt spraying method, electrostatic spinning method, needle punching method, etc. can be cited. Among them, from the perspective of productivity and versatility, wet method, melt spraying method, and electrostatic spinning method are preferred. Porous film refers to a plastic body having countless through holes. As a method for making it, phase separation method, foaming method, etching method by irradiation with radiation or laser light, pore forming method, freeze drying method, plastic sintering method, etc. can be cited. However, from the perspective of complex flow paths and ease of production, porous films using phase separation method are particularly preferred. A ball-packed column is a column in which pores are formed between the balls by packing the column with balls. It is desirable that the particle size of the balls be uniform, and the pore size between the balls can be easily controlled by the particle size of the balls.

作為構成本發明的分離基材之多孔體,例如可舉出不織布、纖維結構體、海綿體、多孔膜等,其中,從生產性及過濾性能的控制性的觀點考慮,不織布為較佳。Examples of the porous body constituting the separation substrate of the present invention include nonwoven fabrics, fiber structures, sponges, and porous membranes. Among them, nonwoven fabrics are preferred from the viewpoint of productivity and controllability of filtering performance.

[分離基材] 本發明的分離基材係由用於從包含巨核細胞及血小板之細胞懸濁液分離血小板之多孔體構成之分離基材。 又,本發明的分離基材具有從細胞懸浮液的流入側依序配置粗過濾層及精密過濾層之區域,粗過濾層包含1片以上的粗過濾膜,精密過濾層為1片以上的精密過濾膜。 又,本發明的分離基材中,粗過濾膜中的至少1片為藉由半乾法測量之平均孔徑成為5.0μm以上且30.0μm以下並且細孔直徑分布的峰值成為小於30%之粗過濾膜X,精密過濾膜中的至少1片為藉由半乾法測量之平均孔徑成為2.0μm以上且20.0μm以下並且細孔直徑分布的峰值成為30%以上之精密過濾膜Y。[Separation substrate] The separation substrate of the present invention is a separation substrate composed of a porous body for separating platelets from a cell suspension containing megakaryocytes and platelets. In addition, the separation substrate of the present invention has a region where a coarse filter layer and a fine filter layer are arranged in order from the inflow side of the cell suspension, the coarse filter layer includes one or more coarse filter membranes, and the fine filter layer is one or more fine filter membranes. Furthermore, in the separation substrate of the present invention, at least one of the coarse filter membranes is a coarse filter membrane X having an average pore size of 5.0 μm or more and 30.0 μm or less as measured by a semi-dry method and a peak value of the pore diameter distribution of less than 30%, and at least one of the precision filter membranes is a precision filter membrane Y having an average pore size of 2.0 μm or more and 20.0 μm or less as measured by a semi-dry method and a peak value of the pore diameter distribution of more than 30%.

在此,“藉由半乾法測量之平均孔徑”係指在使用了perm-porometer(Seika Corporation製造 CFE-1200AEX)之細孔直徑分布測量試驗中,對在GALWICK(Porous Materials,Inc製造)中完全潤濕之樣品吹送空氣,一邊以1kPa/min升壓一邊進行了評價之值。 具體而言,相對於在GALWICK中完全潤濕之膜狀樣品,在膜的一側吹送空氣,以使壓力上升成為1kPa/min,一邊測量其壓力,一邊測量向與膜的相反的一側透過之空氣的流量。 在該方法中,首先關於在GALWICK中潤濕之膜狀樣品,得到壓力與透氣流量的數據(以下,亦稱為“濕曲線”。)。接著,對與未潤濕之乾燥狀態的膜狀樣品相同的數據(以下,亦稱為“乾曲線”。)進行測量,並求出相當於乾曲線的流量的一半之曲線(半乾曲線)與濕曲線的交點的壓力。之後,能夠將GALWICK的表面張力(γ)、與基材的接觸角(θ)及空氣壓(P)導入到下述式(I),計算平均孔徑。 平均孔徑=4γcosθ/P……(I)Here, "average pore size measured by semi-dry method" refers to the value evaluated by blowing air into a sample completely wetted in GALWICK (manufactured by Porous Materials, Inc.) and increasing the pressure by 1 kPa/min in a pore size distribution measurement test using a perm-porometer (CFE-1200AEX manufactured by Seika Corporation). Specifically, air is blown onto one side of a membrane sample completely wetted in GALWICK to increase the pressure to 1 kPa/min, and the pressure is measured while measuring the flow rate of air passing through the opposite side of the membrane. In this method, first, the pressure and air flow rate data (hereinafter also referred to as the "wet curve") are obtained for the film sample moistened in GALWICK. Then, the same data as the dry film sample that has not been moistened (hereinafter also referred to as the "dry curve") are measured, and the pressure at the intersection of the curve (half-dry curve) equivalent to half the flow rate of the dry curve and the wet curve is calculated. After that, the surface tension (γ) of GALWICK, the contact angle (θ) with the substrate, and the air pressure (P) can be introduced into the following formula (I) to calculate the average pore size. Average pore size = 4γcosθ/P……(I)

又,“細孔直徑分布的峰值”係指使用利用在計算上述之平均孔徑時的細孔直徑分布測量試驗中獲得之濕曲線及乾曲線來計算之細孔直徑分布並且藉由以下所示之方法進行了評價之值。 細孔直徑分布為將x軸設為孔徑,將y軸設為孔徑分布之直方圖,將x軸設為對數軸,將數據區間的間隔為0.05、亦即將x軸的孔徑進行10倍化為止的區間設為對數值以等間隔分為20個區分而設定,進而描繪直方圖,以使全區間的度數的總和成為100%,並且將該直方圖的最大度數的評價值作為峰值。In addition, the "peak value of the pore diameter distribution" refers to the value evaluated by the method shown below using the pore diameter distribution calculated using the wet curve and dry curve obtained in the pore diameter distribution measurement test when calculating the above-mentioned average pore diameter. The pore diameter distribution is a histogram with the x-axis being the pore diameter and the y-axis being the pore diameter distribution, the x-axis being the logarithmic axis, the interval of the data interval being 0.05, that is, the interval up to the pore diameter of the x-axis multiplied by 10 being the logarithmic value, and being divided into 20 equal intervals, and then the histogram is drawn so that the sum of the degrees of all intervals becomes 100%, and the evaluation value of the maximum degree of the histogram is set as the peak value.

本發明的分離基材如上述,藉由設置從細胞懸浮液的流入側依序配置包含滿足既定參數之粗過濾膜X之粗過濾層及包含滿足既定參數之精密過濾膜Y之精密過濾層之區域,巨核細胞的去除率及血小板的回收率均高並且過濾壽命變長。 發揮該種效果之理由的詳細雖不明確,但是本發明人等推測如下。 首先,粗過濾膜X中,藉由半乾法測量之平均孔徑為5.0μm以上且30.0μm以下並且細孔直徑分布的峰值小於30%,因此可以說與後述之精密過濾膜Y相比,大量具有具有各種孔徑之細孔。 而且,藉由包含粗過濾膜X之粗過濾層設置於比包含精密過濾膜Y之精密過濾層更靠細胞懸浮液的流入側,認為能夠減少到達精密過濾層之巨核細胞的數,因此一邊較高地維持巨核細胞的去除率及血小板的回收率,一邊能夠延長過濾壽命。尤其,藉由設置包含粗過濾膜X之粗過濾層,在積層膜中的膜與膜的界面中充分產生向膜面平行方向的液體流動,將過濾對象物有效地分散於各個膜的膜面,其結果認為能夠最大限利用膜的有效空隙,因此能夠延長過濾壽命。As described above, the separation substrate of the present invention is provided with a region including a coarse filter layer including a coarse filter membrane X satisfying predetermined parameters and a fine filter layer including a fine filter membrane Y satisfying predetermined parameters in order from the inflow side of the cell suspension, so that the removal rate of megakaryocytes and the recovery rate of platelets are both high and the filtration life is prolonged. Although the details of the reason for exerting such an effect are unclear, the inventors of the present invention speculate as follows. First, in the coarse filter membrane X, the average pore size measured by the semi-dry method is 5.0 μm or more and 30.0 μm or less and the peak value of the pore diameter distribution is less than 30%, so it can be said that it has a large number of pores with various pore sizes compared with the fine filter membrane Y described later. Furthermore, by providing the coarse filter layer including the coarse filter membrane X on the inflow side of the cell suspension than the fine filter layer including the fine filter membrane Y, it is considered that the number of megakaryocytes reaching the fine filter layer can be reduced, thereby maintaining the megakaryocyte removal rate and platelet recovery rate at a high level and extending the filtration life. In particular, by providing the coarse filter layer including the coarse filter membrane X, a liquid flow in a direction parallel to the membrane surface is sufficiently generated at the interface between the membranes in the laminated membrane, and the filtration object is effectively dispersed on the membrane surface of each membrane, and as a result, it is considered that the effective gaps of the membrane can be utilized to the maximum extent, thereby extending the filtration life.

〔粗過濾層〕 本發明的分離基材所具有之粗過濾層為包含1片以上的粗過濾膜之過濾層。 在此,粗過濾膜係指細孔直徑分布的峰值成為小於30%之過濾膜,本發明中,粗過濾膜中的至少1片為藉由半乾法測量之平均孔徑成為5.0μm以上且30.0μm以下並且細孔直徑分布的峰值成為小於30%之粗過濾膜X,粗過濾層中所包含之所有粗過濾膜為粗過濾膜X為較佳。 又,粗過濾層包含2片以上的粗過濾膜之情況下,可以積層相同的粗過濾膜,亦可以積層不同之粗過濾膜。另外,積層不同之粗過濾膜之情況下,相鄰之粗過濾膜的積層順序為以配置於細胞懸浮液的流入側之粗過濾膜的平均孔徑成為配置於流出側之粗過濾膜的平均孔徑以上的方式積層為較佳。[Coarse filter layer] The coarse filter layer of the separation substrate of the present invention is a filter layer comprising one or more coarse filter membranes. Herein, the coarse filter membrane refers to a filter membrane having a peak value of pore diameter distribution of less than 30%. In the present invention, at least one of the coarse filter membranes is a coarse filter membrane X having an average pore diameter of 5.0 μm or more and 30.0 μm or less measured by a semi-dry method and a peak value of pore diameter distribution of less than 30%. It is preferred that all coarse filter membranes contained in the coarse filter layer are coarse filter membranes X. When the coarse filter layer includes two or more coarse filter membranes, the same coarse filter membranes may be laminated or different coarse filter membranes may be laminated. When different coarse filter membranes are laminated, it is preferred that the adjacent coarse filter membranes are laminated in such a manner that the average pore size of the coarse filter membrane disposed on the inflow side of the cell suspension is equal to or larger than the average pore size of the coarse filter membrane disposed on the outflow side.

粗過濾膜1片的厚度並無特別限定,10~1000μm為較佳,15~400μm為更佳,20~200μm為進一步較佳。 在此,“粗過濾膜的厚度”係指使用測微儀(Mitutoyo Corporation製造)在10處測量粗過濾膜的膜厚,並將各測量值進行平均之值。The thickness of one sheet of the coarse filter membrane is not particularly limited, but is preferably 10 to 1000 μm, more preferably 15 to 400 μm, and even more preferably 20 to 200 μm. Here, the "thickness of the coarse filter membrane" refers to the value obtained by measuring the thickness of the coarse filter membrane at 10 locations using a micrometer (manufactured by Mitutoyo Corporation) and averaging the measured values.

本發明中,從分離基材的過濾壽命變得更長之理由考慮,粗過濾層包含3片以上的粗過濾膜為較佳,包含3~20片粗過濾膜為更佳。In the present invention, the coarse filter layer preferably includes 3 or more coarse filter membranes, and more preferably includes 3 to 20 coarse filter membranes, because the filtration life of the separation substrate becomes longer.

<粗過濾膜X> 粗過濾膜X為如上述藉由半乾法測量之平均孔徑成為5.0μm以上且30.0μm以下並且細孔直徑分布的峰值成為小於30%之粗過濾膜。 又,粗過濾膜X的平均孔徑為7.5μm以上且26.0μm以下為較佳,9.0μm以上且23.0μm以下為更佳。 又,粗過濾膜X的細孔直徑分布的峰值為5%以上且小於30%為較佳,10%以上且小於30%為更佳。<Coarse filter membrane X> The coarse filter membrane X is a coarse filter membrane having an average pore size of 5.0 μm or more and 30.0 μm or less as measured by the semi-dry method as described above, and a peak value of the pore size distribution of less than 30%. Moreover, the average pore size of the coarse filter membrane X is preferably 7.5 μm or more and 26.0 μm or less, and more preferably 9.0 μm or more and 23.0 μm or less. Moreover, the peak value of the pore size distribution of the coarse filter membrane X is preferably 5% or more and less than 30%, and more preferably 10% or more and less than 30%.

從分離基材的過濾壽命變得更長之理由考慮,粗過濾膜X為滿足下述式(1)之膜為較佳,滿足下述式(2)之膜為更佳。 150≤平均孔徑(μm)的數值×厚度(μm)的數值≤1500 (1) 150≤平均孔徑(μm)的數值×厚度(μm)的數值≤1200 (2)From the perspective of extending the filtration life of the separation substrate, the coarse filter membrane X is preferably a membrane that satisfies the following formula (1), and more preferably a membrane that satisfies the following formula (2). 150≤Number of average pore size (μm) ×Number of thickness (μm)≤1500 (1) 150≤Number of average pore size (μm) ×Number of thickness (μm)≤1200 (2)

從血小板的回收率變得更高且分離基材的過濾壽命變得更長之理由考慮,粗過濾膜X的孔隙率為40%以上且90%以下為較佳,50%以上且90%以下為更佳。 在此,“孔隙率”係指藉由下述式計算之值。 孔隙率(%)=[1-{m/ρ/(S×d)}]×100 m:薄片重量(g) ρ:樹脂密度(g/cm3 ) S:薄片面積(cm2 ) d:薄片膜厚(cm)In order to increase the recovery rate of platelets and prolong the filtration life of the separation substrate, the porosity of the coarse filter membrane X is preferably 40% or more and 90% or less, and more preferably 50% or more and 90% or less. Here, "porosity" refers to the value calculated by the following formula. Porosity (%) = [1-{m/ρ/(S×d)}]×100 m: sheet weight (g) ρ: resin density (g/cm 3 ) S: sheet area (cm 2 ) d: sheet membrane thickness (cm)

〔精密過濾層〕 本發明的分離基材所具有之精密過濾層為包含1片以上的精密過濾膜之過濾層。 在此,精密過濾膜係指細孔直徑分布的峰值成為30%以上之過濾膜,本發明中,精密過濾膜中的至少1片為藉由半乾法測量之平均孔徑成為2.0μm以上且20.0μm以下並且細孔直徑分布的峰值成為30%以上之精密過濾膜Y,精密過濾層中所包含之所有精密過濾膜為精密過濾膜Y為較佳。 又,精密過濾層包含2片以上的精密過濾膜之情況下,可以積層相同的精密過濾膜,亦可以積層不同之精密過濾膜。另外,積層不同之精密過濾膜之情況下,相鄰之精密過濾膜的積層順序為以配置於細胞懸浮液的流入側之精密過濾膜的平均孔徑成為配置於流出側之精密過濾膜的平均孔徑以上的方式積層為較佳。[Precision filter layer] The precision filter layer of the separation substrate of the present invention is a filter layer comprising one or more precision filter membranes. Here, the precision filter membrane refers to a filter membrane having a peak value of pore diameter distribution of 30% or more. In the present invention, at least one of the precision filter membranes is a precision filter membrane Y having an average pore diameter of 2.0 μm or more and 20.0 μm or less measured by a semi-dry method and a peak value of pore diameter distribution of 30% or more. It is preferred that all precision filter membranes contained in the precision filter layer are precision filter membranes Y. Furthermore, when the precision filter layer includes two or more precision filter membranes, the same precision filter membranes may be laminated or different precision filter membranes may be laminated. Furthermore, when different precision filter membranes are laminated, it is preferred that the adjacent precision filter membranes are laminated in such a manner that the average pore size of the precision filter membrane disposed on the inflow side of the cell suspension is equal to or larger than the average pore size of the precision filter membrane disposed on the outflow side.

精密過濾膜1片的厚度並無特別限定,10~500μm為較佳,10~250μm為更佳,10~200μm為進一步較佳。 在此,“精密過濾膜的厚度”係指使用測微儀(Mitutoyo Corporation製造)在10處測量精密過濾膜的膜厚,並將各測量值進行平均之值。The thickness of one precision filter membrane is not particularly limited, but is preferably 10 to 500 μm, more preferably 10 to 250 μm, and even more preferably 10 to 200 μm. Here, the "thickness of the precision filter membrane" refers to the value obtained by measuring the thickness of the precision filter membrane at 10 locations using a micrometer (manufactured by Mitutoyo Corporation) and averaging the measured values.

本發明中,從分離基材的過濾壽命變得更長之理由考慮,精密過濾層包含2片以上的精密過濾膜為較佳,包含2~10片精密過濾膜為更佳。In the present invention, from the perspective of extending the filtration life of the separation substrate, the precision filter layer preferably includes two or more precision filter membranes, and more preferably includes 2 to 10 precision filter membranes.

<精密過濾膜Y> 精密過濾膜Y為如上述藉由半乾法測量之平均孔徑成為2.0μm以上且20.0μm以下並且細孔直徑分布的峰值成為30%以上之精密過濾膜。 又,精密過濾膜Y的平均孔徑為2.0μm以上且17.5μm以下為較佳,2.0μm以上且15.0μm以下為更佳。 又,精密過濾膜Y的細孔直徑分布的峰值為30%以上且99%以下為較佳,45%以上且99%以下為更佳。<Precision filter membrane Y> Precision filter membrane Y is a precision filter membrane having an average pore size of 2.0 μm or more and 20.0 μm or less as measured by the semi-dry method as described above, and a peak value of pore diameter distribution of 30% or more. Preferably, the average pore size of precision filter membrane Y is 2.0 μm or more and 17.5 μm or less, and more preferably, 2.0 μm or more and 15.0 μm or less. Preferably, the peak value of pore diameter distribution of precision filter membrane Y is 30% or more and 99% or less, and more preferably, 45% or more and 99% or less.

從血小板的回收率變得更高且分離基材的過濾壽命變得更長之理由考慮,精密過濾膜Y的孔隙率為40%以上且90%以下為較佳,50%以上且90%以下為更佳。From the perspective of increasing the recovery rate of platelets and extending the filtration life of the separation substrate, the porosity of the precision filtration membrane Y is preferably 40% to 90%, and more preferably 50% to 90%.

本發明中,從分離基材的過濾壽命變得更長之理由考慮,上述之粗過濾層中所包含之所有粗過濾膜及上述之精密過濾層中所包含之所有精密過濾膜的臨界潤濕表面張力(Critical Wetting Surface Tension:CWST)為72mN/m以上的膜為較佳,72~110mN/m的膜為更佳。 在此,“臨界潤濕表面張力”係指藉由以下順序計算之值。 首先,使用具有不同表面張力之溶液,將1滴溶液輕輕地滴加於水平之過濾膜上,放置10分鐘。 過濾膜潤濕之情況下,使用具有高於進行潤濕之溶液之表面張力之溶液同樣地進行滴加,重複進行直至不再潤濕。 接著,關於在經潤濕之溶液中具有最大表面張力之溶液及在未經潤濕之溶液中具有最小表面張力之溶液,將兩種溶液的表面張力的平均值作為臨界潤濕表面張力而計算。In the present invention, from the perspective of extending the filtration life of the separation substrate, the critical wetting surface tension (Critical Wetting Surface Tension: CWST) of all the coarse filter membranes included in the coarse filter layer and all the fine filter membranes included in the fine filter layer is preferably 72 mN/m or more, and 72 to 110 mN/m is more preferably. Here, "critical wetting surface tension" refers to the value calculated by the following procedure. First, using solutions with different surface tensions, 1 drop of the solution is gently dropped on a horizontal filter membrane and left for 10 minutes. When the filter membrane is wetted, a solution with a higher surface tension than the solution being wetted is added dropwise in the same manner, and this process is repeated until no more wetting occurs. Then, the average of the surface tensions of the solution with the largest surface tension in the wetted solution and the solution with the smallest surface tension in the unwetted solution is calculated as the critical wetting surface tension.

作為將臨界潤濕表面張力調節為上述之範圍內之方法,能夠採用各種表面處理法。 作為表面處理法,例如可舉出親水性原材料的表面塗佈、基於鹼皂化等之至親水性官能基的轉換或者賦予等。 又,關於塗佈材料,能夠使用公知的材料,不具有血小板吸附性為特佳。As a method for adjusting the critical wetting surface tension within the above range, various surface treatment methods can be adopted. As surface treatment methods, for example, surface coating of hydrophilic raw materials, conversion or addition of hydrophilic functional groups based on alkali saponification, etc. can be cited. In addition, as for the coating material, known materials can be used, and it is particularly preferred that the coating material does not have platelet adsorption.

本發明中,關於上述之粗過濾層及精密過濾層,粗過濾層的流出側的平均孔徑成為精密過濾層的流入側的平均孔徑以上為較佳。In the present invention, regarding the above-mentioned coarse filter layer and fine filter layer, it is preferred that the average pore size on the outflow side of the coarse filter layer is equal to or larger than the average pore size on the inflow side of the fine filter layer.

本發明的分離基材係具有從細胞懸浮液的流入側依序配置有上述之粗過濾層及精密過濾層之區域者,但是該區域的總體積相對於分離基材的總體積為50%以上為較佳,65~100%為更佳。The separation substrate of the present invention has a region in which the above-mentioned coarse filter layer and fine filter layer are arranged in order from the inflow side of the cell suspension, but the total volume of the region is preferably 50% or more, and more preferably 65-100% relative to the total volume of the separation substrate.

本發明的分離基材的厚度為100~3000μm為較佳,150~1000μm為更佳。 在此,“分離基材的厚度”係指使用測微儀(Mitutoyo Corporation製造)在10處測量分離基材的膜厚,並將各測量值進行平均之值。The thickness of the separation substrate of the present invention is preferably 100 to 3000 μm, and more preferably 150 to 1000 μm. Here, "the thickness of the separation substrate" refers to the value obtained by measuring the film thickness of the separation substrate at 10 locations using a micrometer (manufactured by Mitutoyo Corporation) and averaging the measured values.

本發明中,從能夠兼顧充分的纖維強度及良好的分離性能之理由考慮,構成多孔體(尤其,不織布)之纖維的平均纖維直徑為800nm以上且3500nm以下為較佳。 又,從使用分離基材時(例如過濾時等)能夠防止纖維的剝離之理由考慮,構成不織布之纖維的平均纖維長度為1mm以上且1m以下為較佳。 另外,平均纖維直徑及平均纖維長度能夠藉由調節製作不織布時的原料(例如乙酸纖維素等)溶液的濃度等的製造條件來調節。In the present invention, the average fiber diameter of the fibers constituting the porous body (especially, nonwoven fabric) is preferably 800 nm or more and 3500 nm or less, from the perspective of being able to take into account both sufficient fiber strength and good separation performance. In addition, the average fiber length of the fibers constituting the nonwoven fabric is preferably 1 mm or more and 1 m or less, from the perspective of being able to prevent fiber peeling when using a separation substrate (for example, during filtration). In addition, the average fiber diameter and the average fiber length can be adjusted by adjusting the manufacturing conditions such as the concentration of the raw material (for example, cellulose acetate, etc.) solution when making the nonwoven fabric.

在此,平均纖維直徑係指如下測量之值。 關於由纖維構成之不織布的表面,觀察透射型電子顯微鏡(Transmission Electron Microscope:TEM)像或掃描型電子顯微鏡(Scanning Electron Microscope:SEM)像。 依據所構成之纖維的大小,在從1000~5000倍選擇之倍率下進行基於電子顯微鏡圖像之觀察。其中,試樣、觀察條件或倍率調節為滿足下述的條件。 (1)在觀察圖像內的任意部位畫出一根直線X,20根以上的纖維與該直線X交叉。 (2)在相同的圖像內畫出與直線X垂直交叉之直線Y,20根以上的纖維與直線Y交叉。 對與如上述的電子顯微鏡觀察圖像,關於各個與直線X相交之纖維、與直線Y相交之纖維分別讀取至少20根(亦即,合計為至少40根)的寬度(纖維的短直徑)。如此觀察至少3組以上如上述的電子顯微鏡圖像,讀取至少40根×3組(亦即,至少120本)的纖維直徑。 如上所述,對讀取之纖維直徑進行平均來求出平均纖維直徑。Here, the average fiber diameter refers to the value measured as follows. The surface of a nonwoven fabric composed of fibers is observed using a transmission electron microscope (TEM) image or a scanning electron microscope (SEM) image. The electron microscope image is observed at a magnification selected from 1000 to 5000 times depending on the size of the fibers. The sample, observation conditions, or magnification are adjusted to meet the following conditions. (1) A straight line X is drawn at any position in the observation image, and 20 or more fibers intersect the straight line X. (2) A straight line Y is drawn in the same image, which intersects the straight line X at right angles, and 20 or more fibers intersect the straight line Y. For the electron microscope observation image as described above, read the width (short diameter of the fiber) of at least 20 fibers (i.e., at least 40 fibers in total) for each fiber intersecting with the straight line X and the straight line Y. Observe at least 3 groups of electron microscope images as described above in this way, and read the fiber diameters of at least 40 fibers × 3 groups (i.e., at least 120 fibers). As described above, the fiber diameters read are averaged to obtain the average fiber diameter.

又,平均纖維長係指如下測量之值。 亦即,纖維的纖維長度能夠藉由分析測量上述之平均纖維直徑時所使用之電子顯微鏡觀察圖像來求出。 具體而言,對與如上述的電子顯微鏡觀察圖像,關於各個與直線X相交之纖維、與直線Y相交之纖維分別讀取至少20根(亦即,合計為至少40根)的纖維長度。 如此觀察至少3組以上如上述的電子顯微鏡圖像,讀取至少40根×3組(亦即,至少120根)的纖維長度。 如上所述,對讀取之纖維長度進行平均來求出平均纖維長度。In addition, the average fiber length refers to the value measured as follows. That is, the fiber length of the fiber can be obtained by analyzing the electron microscope observation image used when measuring the above-mentioned average fiber diameter. Specifically, for the electron microscope observation image as described above, the fiber lengths of at least 20 fibers (that is, at least 40 fibers in total) are read for each fiber intersecting with the straight line X and the fiber intersecting with the straight line Y. In this way, at least 3 groups of electron microscope images as described above are observed, and the fiber lengths of at least 40 fibers × 3 groups (that is, at least 120 fibers) are read. As described above, the average fiber length is obtained by averaging the read fiber lengths.

本發明的分離基材包含樹脂材料為較佳。 作為樹脂材料,具體而言,例如可舉出纖維素醯化物、纖維素等纖維素樹脂;聚丙烯腈樹脂;聚碸樹脂;氟樹脂;聚醚碸樹脂;聚醯胺樹脂;聚丙烯等聚烯烴樹脂等,可以使用單獨一種該等,亦可以併用2種以上。 該等中,包含選自包括纖維素樹脂及聚烯烴樹脂之群組中之至少1種樹脂為較佳。The separation substrate of the present invention preferably includes a resin material. As the resin material, specifically, for example, cellulose resins such as cellulose acylate and cellulose; polyacrylonitrile resin; polyester resin; fluororesin; polyether polyester resin; polyamide resin; polypropylene and other polyolefin resins, etc., can be cited. A single type of these can be used, or two or more types can be used in combination. Among these, it is preferred to include at least one resin selected from the group including cellulose resins and polyolefin resins.

作為上述纖維素樹脂,纖維素醯化物或纖維素為較佳。 又,纖維素醯化物可以為一部分被皂化之纖維素醯化物。 又,作為纖維素醯化物所具有之醯基,具體而言,例如可舉出乙醯基、丙醯基及丁醯基等。另外,經取代之醯基可以僅為1種(例如,僅為乙醯基),亦可以為2種以上。As the above-mentioned cellulose resin, cellulose acylation or cellulose is preferred. In addition, cellulose acylation may be a partially saponified cellulose acylation. In addition, as the acyl group possessed by the cellulose acylation, specifically, for example, acetyl, propionyl, and butyryl can be mentioned. In addition, the substituted acyl group may be only one type (for example, only acetyl) or may be two or more types.

作為上述聚烯烴樹脂,聚丙烯為較佳,經親水化處理之聚丙烯為更佳。As the polyolefin resin, polypropylene is preferred, and hydrophilized polypropylene is more preferred.

本發明中,從抑制血小板吸附於分離基材並且更加提高血小板的透過率之觀點考慮,亦可以對分離基材的表面實施親水化處理而化學或物理改質血小板低吸附材料。 作為血小板低吸附材料,在側鏈具有親水性基之聚合物為較佳,例如可舉出2-甲基丙烯醯氧基乙基磷酸膽鹼、乙二醇、甲基丙烯酸甲酯、羥基乙基甲基丙烯酸酯、乙烯醇、N-乙烯-2-吡咯烷酮、磺基甜菜鹼單體的聚合物等。 作為親水性基,具體而言,例如可舉出羥基、醚基、硝基、亞胺基、羰基、磷酸基、甲氧基二乙二醇基、甲氧基三乙二醇基、乙氧基二乙二醇基、乙氧基三乙二醇基、胺基、二甲基胺基、二乙基胺基、羧基、磷醯基、磷酸膽鹼基、硫酸基或該等的鹽等。 又,作為血小板低吸附材料及其改質方法,能夠利用WO87/05812、日本特開平4-152952、日本特開平5-194243、WO2010/113632等中所記載之材料及方法。In the present invention, from the perspective of inhibiting platelet adsorption to the separation substrate and further improving the permeability of platelets, the surface of the separation substrate can be hydrophilized to chemically or physically modify the platelet low adsorption material. As a platelet low adsorption material, a polymer having a hydrophilic group in the side chain is preferred, for example, 2-methacryloyloxyethyl phosphocholine, ethylene glycol, methyl methacrylate, hydroxyethyl methacrylate, vinyl alcohol, N-vinyl-2-pyrrolidone, and a polymer of a sulfobetaine monomer can be cited. As the hydrophilic group, specifically, for example, there can be cited a hydroxyl group, an ether group, a nitro group, an imino group, a carbonyl group, a phosphate group, a methoxydiethylene glycol group, a methoxytriethylene glycol group, an ethoxydiethylene glycol group, an ethoxytriethylene glycol group, an amino group, a dimethylamino group, a diethylamino group, a carboxyl group, a phosphoyl group, a phosphocholine group, a sulfate group or salts thereof. In addition, as a platelet low adsorption material and a modification method thereof, the materials and methods described in WO87/05812, Japanese Patent Laid-Open No. 4-152952, Japanese Patent Laid-Open No. 5-194243, WO2010/113632, etc. can be used.

〔細胞懸濁液〕 使用本發明的分離基材供於血小板的分離之細胞懸濁液係包含巨核細胞及血小板之細胞懸濁液。 其中,巨核細胞及血小板並無特別限定,例如可舉出從成體組織採取之巨核細胞及血小板;從具有多能性乾細胞、造血祖細胞及間充質細胞等分化全能性之細胞分化之巨核細胞及血小板;在通常的方法中在不具有至巨核細胞的分化全能性之細胞藉由使用直接重新編程技術製作之巨核細胞及血小板;組合該等之巨核細胞及血小板;等。[Cell suspension] The cell suspension used for separation of platelets using the separation substrate of the present invention is a cell suspension containing megakaryocytes and platelets. Among them, megakaryocytes and platelets are not particularly limited, and examples thereof include megakaryocytes and platelets collected from adult tissues; megakaryocytes and platelets differentiated from cells having differentiation totipotency such as pluripotent stem cells, hematopoietic progenitor cells, and mesenchymal cells; megakaryocytes and platelets produced by direct reprogramming technology from cells that do not have differentiation totipotency to megakaryocytes in conventional methods; combinations of these megakaryocytes and platelets; etc.

作為多能性乾細胞,例如可舉出胚性乾細胞〔ES(embryonic stem)細胞〕、核移植胚性乾細胞〔nt(nuclear transfer)ES細胞〕及人工多能性乾細胞〔iPS(induced pluripotent stem)細胞〕等,其中,人工多能性乾細胞(iPS細胞)為較佳。 作為造血祖細胞,例如可舉出來自於骨髓、來自於臍帶血、動員〔G-CSF(Granulocyte-colony stimulating factor,顆粒性白血球群落刺激因子)〕末梢血、來自於ES細胞的中肺葉系細胞及來自於末梢血的細胞等,但是並不限定於該等。作為該等造血祖細胞,例如可舉出分化抗原群(cluster of differentiation:CD)34陽性者(例如,CD34+細胞、CD133+細胞、SP細胞、CD34+CD38-細胞、c-kit+細胞或者CD3-、CD4-、CD8-及CD34+細胞者)(國際公開WO2004/110139)。 作為間充質細胞,例如可舉出間充質乾細胞、脂肪祖細胞、骨髓細胞、脂肪細胞及滑膜細胞等,其中,脂肪祖細胞為較佳。 在通常的方法中,作為不具有至巨核細胞的分化全能性之細胞,例如可舉出纖維芽細胞等,但是並不限定於該等。Examples of pluripotent stem cells include embryonic stem cells [ES (embryonic stem) cells], nuclear transfer embryonic stem cells [nt (nuclear transfer) ES cells], and artificial pluripotent stem cells [iPS (induced pluripotent stem) cells], among which artificial pluripotent stem cells (iPS cells) are preferred. Examples of hematopoietic progenitor cells include cells from bone marrow, cord blood, mobilized [G-CSF (Granulocyte-colony stimulating factor)] peripheral blood, mid-lobar cells derived from ES cells, and cells from peripheral blood, but are not limited to these. Examples of such hematopoietic progenitor cells include cluster of differentiation (CD) 34 positive cells (e.g., CD34+ cells, CD133+ cells, SP cells, CD34+CD38- cells, c-kit+ cells, or CD3-, CD4-, CD8-, and CD34+ cells) (International Publication No. WO2004/110139). Examples of such mesenchymal cells include mesenchymal stem cells, adipose progenitor cells, bone marrow cells, fat cells, and synovial cells, among which adipose progenitor cells are preferred. In conventional methods, as cells that do not have the totipotency to differentiate into megakaryocytes, for example, fibroblasts can be cited, but the present invention is not limited to these.

[細胞分離過濾器] 本發明的細胞分離過濾器具備:容器,配置有第1通液口及第2通液口;及過濾材料,填充於第1通液口及第2通液口之間,其中在過濾材料中使用了上述之本發明的分離基材。[Cell separation filter] The cell separation filter of the present invention comprises: a container having a first liquid port and a second liquid port; and a filter material filled between the first liquid port and the second liquid port, wherein the separation substrate of the present invention is used in the filter material.

細胞分離過濾器中所使用之容器的形態、大小、材質並無特別限定。 作為容器的形態,例如可以為球、容器、盒狀、袋狀、管狀、管柱狀等、任意的形態。 作為容器的型(類型),亦能夠使用橫向類型及管柱狀類型中的任一個類型。The shape, size, and material of the container used in the cell separation filter are not particularly limited. The container may be in any shape, such as a sphere, a container, a box, a bag, a tube, a column, etc. The container may be in any shape, such as a horizontal type or a columnar type.

[血小板之製造方法] 本發明的血小板之製造方法具有: 接觸步驟,使至少包含巨核細胞之培養液與上述之本發明的分離基材接觸; 培養步驟,在接觸步驟之前及/或之後,培養巨核細胞而產生血小板;及 回收步驟,在接觸步驟及培養步驟之後,回收包含所產生之血小板之培養液。 其中,接觸步驟中的接觸機構能夠依據培養液的量及巨核細胞的濃度等來適當選擇,但是例如可舉出在填充有本發明的分離基材之塔或管柱等供給細胞懸濁液之方法等。 又,培養步驟中的產生血小板之方法,例如可舉出藉由流體供給剪切應力之方法,具體而言可舉出攪拌包含巨核細胞之培養液之方法等。另外,培養步驟中培養之巨核細胞可以為在接觸步驟之後具有培養步驟之情況下藉由本發明的分離基材中補充之巨核細胞。又,認為接觸步驟之後具有培養步驟之情況下如後述之實施例那樣使包含巨核細胞及血小板之細胞懸濁液與分離基材接觸時在初期階段補充之巨核細胞,藉由基於之後接觸之細胞懸濁液(亦即流體)之剪切應力,亦產生血小板。 又,作為回收步驟中的回收方法,例如可舉出在填充有本發明的分離基材之塔或管柱狀等使包含所產生之血小板之培養液通液之方法等。 [實施例][Method for producing platelets] The method for producing platelets of the present invention comprises: a contacting step of bringing a culture medium containing at least megakaryocytes into contact with the above-mentioned separation substrate of the present invention; a culturing step of culturing megakaryocytes to produce platelets before and/or after the contacting step; and a recovery step of recovering the culture medium containing the produced platelets after the contacting step and the culturing step. The contacting mechanism in the contacting step can be appropriately selected according to the amount of the culture medium and the concentration of megakaryocytes, but for example, a method of supplying a cell suspension to a tower or column filled with the separation substrate of the present invention can be cited. In addition, the method of producing platelets in the culture step includes, for example, a method of applying shear stress by a fluid, and specifically, a method of stirring a culture medium containing megakaryocytes, etc. In addition, the megakaryocytes cultured in the culture step may be megakaryocytes supplemented by the separation substrate of the present invention when the culture step is performed after the contacting step. Furthermore, when there is a culture step after the contact step, as in the embodiment described later, when the cell suspension containing megakaryocytes and platelets is brought into contact with the separation substrate, the megakaryocytes replenished in the early stage are considered to also produce platelets due to the shear stress of the cell suspension (i.e., fluid) that is subsequently contacted. In addition, as a recovery method in the recovery step, for example, a method of passing the culture solution containing the produced platelets through a tower or column filled with the separation substrate of the present invention can be cited. [Example]

以下,根據實施例對本發明進行進一步詳細的說明。以下的實施例中所示之材料、使用量、比例、處理內容、處理步驟等只要不脫離本發明的宗旨,則能夠適當變更。然而,本發明的範圍並非係被以下所示之實施例限定地解釋者。The present invention is further described in detail below based on the embodiments. The materials, usage amounts, ratios, processing contents, processing steps, etc. shown in the following embodiments can be appropriately changed as long as they do not deviate from the purpose of the present invention. However, the scope of the present invention is not limited to the embodiments shown below.

〔粗過濾膜的製作〕 將聚丙烯(PP)用於原料,使用熔噴法製作不織布,依據需要進行壓光處理之後,進行親水化塗佈處理,從而製作了由不織布構成之粗過濾膜R1~R13。 在此,關於壓光處理,調節溫度、壓力、輸送速度來進行,以使成為下述表1所記載之孔隙率。 又,關於親水化塗佈,調節日本專利第3250833號記載的條件對甲氧基聚乙二醇甲基丙烯酸酯的大分子單體進行接枝聚合來進行,以使成為下述表1所示之CWST。 另外,關於平均孔徑、厚度、細孔分布的峰值及孔隙率不同之粗過濾膜,藉由調節重量、聚合物吐出速度或溫度等的不織布的製造條件,獲得了下述表1所記載之粗過濾膜。 另外,關於經製作之粗過濾膜R1~R13,藉由上述之方法測量平均孔徑、厚度、CWST、細孔直徑分布的峰值及孔隙率,又計算了平均孔徑與厚度的乘積(上述式(1)的值)。將該等結果示於下述表1中。[Preparation of coarse filter membrane] Using polypropylene (PP) as a raw material, a nonwoven fabric was prepared by melt-blowing, and after calendering treatment as needed, a hydrophilic coating treatment was performed to prepare coarse filter membranes R1 to R13 composed of nonwoven fabrics. Here, regarding the calendering treatment, the temperature, pressure, and conveying speed were adjusted to achieve the porosity described in Table 1 below. In addition, regarding the hydrophilic coating, the macromolecular monomer of methoxy polyethylene glycol methacrylate was graft-polymerized under the conditions described in Japanese Patent No. 3250833 to achieve the CWST shown in Table 1 below. In addition, for coarse filter membranes with different average pore diameters, thicknesses, peak values of pore distribution, and porosity, the coarse filter membranes listed in Table 1 below were obtained by adjusting the manufacturing conditions of the nonwoven fabric such as weight, polymer extrusion speed, or temperature. In addition, for the coarse filter membranes R1 to R13 prepared, the average pore diameter, thickness, CWST, peak value of pore diameter distribution, and porosity were measured by the above method, and the product of the average pore diameter and thickness (the value of the above formula (1)) was calculated. The results are shown in Table 1 below.

[表1]   多孔體 原材料 壓光處理 塗佈處理 平均孔徑 (μm) 厚度 (μm) CWST (mN/m) 細孔直徑分布峰值 孔隙率 平均孔徑×厚度 粗過濾膜R1 不織布 PP 4.0 75 73 11% 41% 300 粗過濾膜R2 不織布 PP 5.2 28 73 22% 49% 146 粗過濾膜R3 不織布 PP 5.1 30 73 16% 63% 153 粗過濾膜R4 不織布 PP 11.0 85 75 23% 81% 935 粗過濾膜R5 不織布 PP 17.0 66 76 19% 80% 1122 粗過濾膜R6 不織布 PP 28.0 53 74 19% 77% 1484 粗過濾膜R7 不織布 PP 27.2 56 74 25% 68% 1523 粗過濾膜R8 不織布 PP 32.0 44 78 27% 57% 1408 粗過濾膜R9 不織布 PP 10.6 60 73 19% 36% 636 粗過濾膜R10 不織布 PP 12.3 120 73 19% 91% 1476 粗過濾膜R11 不織布 PP 17.0 66 70 19% 67% 1122 粗過濾膜R12 不織布 PP 10.9 70 73 21% 42% 763 粗過濾膜R13 不織布 PP 11.2 125 73 20% 89% 1400 [Table 1] Porous body Raw materials Calendering Coating treatment Average pore size (μm) Thickness (μm) CWST (mN/m) Peak value of pore diameter distribution Porosity Average pore diameter × thickness Coarse filter membrane R1 Non-woven fabric PP without have 4.0 75 73 11% 41% 300 Coarse filter membrane R2 Non-woven fabric PP without have 5.2 28 73 twenty two% 49% 146 Coarse filter membrane R3 Non-woven fabric PP without have 5.1 30 73 16% 63% 153 Coarse filter membrane R4 Non-woven fabric PP without have 11.0 85 75 twenty three% 81% 935 Coarse filter membrane R5 Non-woven fabric PP without have 17.0 66 76 19% 80% 1122 Coarse filter membrane R6 Non-woven fabric PP without have 28.0 53 74 19% 77% 1484 Coarse filter membrane R7 Non-woven fabric PP without have 27.2 56 74 25% 68% 1523 Coarse filter membrane R8 Non-woven fabric PP without have 32.0 44 78 27% 57% 1408 Coarse filter membrane R9 Non-woven fabric PP have have 10.6 60 73 19% 36% 636 Coarse filter membrane R10 Non-woven fabric PP without have 12.3 120 73 19% 91% 1476 Coarse filter membrane R11 Non-woven fabric PP without have 17.0 66 70 19% 67% 1122 Coarse filter membrane R12 Non-woven fabric PP without have 10.9 70 73 twenty one% 42% 763 Coarse filter membrane R13 Non-woven fabric PP without have 11.2 125 73 20% 89% 1400

〔精密過濾膜的製作〕 使用電紡法,在下述表2所示之條件下,製作了由不織布構成之精密過濾膜P1~P10。 具體而言,藉由與專利文獻1(國際公開第2018/207564號)的實施例1相同的方法,製作了由乙酸纖維素(以下,亦簡稱為“CA”。)及/或乙酸丙酸纖維素(以下,亦簡稱為“CAP”。)構成之不織布。另外,關於平均孔徑、厚度、細孔分布的峰值及孔隙率不同之精密過濾膜,藉由調節重量、加熱處理溫度及加熱處理時間,獲得了下述表2中所記載之精密過濾膜。 接著,使用氫氧化鈉的水/乙醇溶液,實施鹼皂化處理,進行了CWST的調節。 接著,浸漬於純水中,取出並且進行風乾,藉此製作了精密過濾膜P1~P10。 另外,關於所製作之精密過濾膜P1~P10,藉由上述之方法測量了平均孔徑、厚度、CWST、細孔直徑分布的峰值及孔隙率。將該等結果示於下述表2中。[Preparation of precision filter membrane] Precision filter membranes P1 to P10 composed of nonwoven fabrics were prepared using the electrospinning method under the conditions shown in Table 2 below. Specifically, nonwoven fabrics composed of cellulose acetate (hereinafter also referred to as "CA") and/or cellulose acetate propionate (hereinafter also referred to as "CAP") were prepared by the same method as Example 1 of Patent Document 1 (International Publication No. 2018/207564). In addition, precision filter membranes with different average pore diameters, thicknesses, peak values of pore distribution, and porosities were obtained by adjusting weight, heat treatment temperature, and heat treatment time to obtain precision filter membranes listed in Table 2 below. Next, an alkaline saponification treatment was performed using a water/ethanol solution of sodium hydroxide to adjust the CWST. Then, the membranes were immersed in pure water, taken out and air-dried to produce precision filter membranes P1 to P10. In addition, the average pore size, thickness, CWST, peak value of pore size distribution and porosity of the produced precision filter membranes P1 to P10 were measured by the above method. The results are shown in Table 2 below.

[表2]   多孔體 原材料 平均孔徑 (μm) 厚度 (μm) CWST (mN/m) 細孔直徑分布峰值 孔隙率 精密過濾膜P1 不織布 CAP 7.0 45 78 80% 70% 精密過濾膜P2 不織布 CAP 1.5 30 75 32% 74% 精密過濾膜P3 不織布 CAP 2.0 150 73 32% 63% 精密過濾膜P4 不織布 CA/ CAP 18.0 80 80 66% 65% 精密過濾膜P5 不織布 CA/ CAP 21.0 70 80 66% 66% 精密過濾膜P6 不織布 CAP 5.4 20 77 80% 33% 精密過濾膜P7 不織布 CAP 7.0 100 85 39% 91% 精密過濾膜P8 不織布 CAP 7.0 45 69 80% 70% 精密過濾膜P9 不織布 CAP 6.5 25 74 78% 40% 精密過濾膜P10 不織布 CAP 6.7 90 73 63% 88% [Table 2] Porous body Raw materials Average pore size (μm) Thickness (μm) CWST (mN/m) Peak value of pore diameter distribution Porosity Precision filter membrane P1 Non-woven fabric CAP 7.0 45 78 80% 70% Precision filter membrane P2 Non-woven fabric CAP 1.5 30 75 32% 74% Precision filter membrane P3 Non-woven fabric CAP 2.0 150 73 32% 63% Precision filter membrane P4 Non-woven fabric CA/ CAP 18.0 80 80 66% 65% Precision filter membrane P5 Non-woven fabric CA/ CAP 21.0 70 80 66% 66% Precision filter membrane P6 Non-woven fabric CAP 5.4 20 77 80% 33% Precision filter membrane P7 Non-woven fabric CAP 7.0 100 85 39% 91% Precision filter membrane P8 Non-woven fabric CAP 7.0 45 69 80% 70% Precision filter membrane P9 Non-woven fabric CAP 6.5 25 74 78% 40% Precision filter membrane P10 Non-woven fabric CAP 6.7 90 73 63% 88%

〔細胞懸浮液的製備〕 培養基:使用了向RPMI1640(Thermo Fisher Scientific製造)450ml添加了牛血清(Thermo Fisher Scientific製造)50ml者。 巨核細胞:將MEG-01(ATCC公司製造)用作巨核細胞。將其與培養基混合,藉此製備了巨核細胞液(6×105 cells/ml)。 血小板懸濁液:將從鼠末梢血單離者用作血小板。具體而言,在裝入有檸檬酸-葡萄糖溶液(ACD)(sigma-aldrich公司)之15ml離心分離用錐形管狀(Falcon公司)回收了從鼠採血之全血10ml。在300×g、室溫下進行7分鐘離心,回收了離心後的Plasma層及Buffy coat層。相同地對回收液進行離心分離,僅回收了Plasma層之後,在1800×g、室溫下進行5分鐘離心,回收上清液,藉此測到了血小板。將其與培養基進行混合,藉此製備了血小板懸濁液(2×108 cells/ml)。 等量混合巨核細胞液及血小板懸濁液,藉此製備了細胞懸濁液。[Preparation of cell suspension] Culture medium: RPMI1640 (manufactured by Thermo Fisher Scientific) 450 ml with 50 ml of bovine serum (manufactured by Thermo Fisher Scientific) added was used. Megakaryocytes: MEG-01 (manufactured by ATCC) was used as megakaryocytes. This was mixed with the culture medium to prepare a megakaryocyte suspension (6×10 5 cells/ml). Platelet suspension: Platelets isolated from mouse peripheral blood were used as platelets. Specifically, 10 ml of whole blood collected from a mouse was collected in a 15 ml conical tube for centrifugation separation (Falcon) filled with citrate-dextrose solution (ACD) (Sigma-Aldrich). The plasma layer and the buffy coat layer were recovered after centrifugation at 300×g and room temperature for 7 minutes. The recovered solution was centrifuged and separated in the same manner, and only the plasma layer was recovered. The recovered solution was then centrifuged at 1800×g and room temperature for 5 minutes, and the supernatant was recovered to detect platelets. This was mixed with the culture medium to prepare a platelet suspension (2×10 8 cells/ml). The megakaryocyte suspension and the platelet suspension were mixed in equal amounts to prepare a cell suspension.

[實施例1~26及比較例1~10] 〔評價1〕 將所製作之各粗過濾膜及各精密過濾膜切成25mmφ圓形,將以成為下述表3所記載之積層構成的方式積層而製作之分離基材組裝於市售的過濾器支撐架上。 接著,在過濾器支撐架的流入側及流出側連接有內徑3mm、長度30cm的聚氯乙烯製的軟管。 將拆卸活塞之注射器連接於流入側的軟管的末端,用夾具固定注射器部而懸掛成注射器、軟管、過濾器支撐架沿鉛錘方向排列。 又,於連接有軟管之狀態下,以過濾器支撐架的流入側成為下側、流出側成為上側的方式進行上下反轉,以免軟管破裂,並且夾具固定於從注射器底部至20cm下的位置。 又,對靠近軟管的注射器底部之部位進行夾具固定且封閉之後,將細胞懸浮液導入注射器中。 接著,開放夾子,將細胞懸浮液導入過濾器中,使之與分離基材接觸。 接著,確認到濾液從過濾器支撐架的流出側流出之後,從夾具上拆卸過濾器支撐架,注射器、軟管、過濾器支撐架返回到沿鉛錘方向排列之配置,回收了所流出之濾液。 濾液以一定液量分小部分回收,對各個液體測量了血小板的回收率及巨核細胞的去除率。 過濾時,將流量成為過濾開始時的一半的值為止的通液量作為過濾壽命而進行了評價。 又,關於血小板的回收率及巨核細胞的去除率,用該過濾壽命為止的平均性能進行了評價。 將該等結果示於下述表3中。另外,下述表3中,“粗過濾膜等”中所記載之膜設置於細胞懸浮液的流入側,“精密過濾膜等”中所記載之膜設置於“粗過濾膜等”中所記載之膜的流出側。又,“粗過濾膜等”及“精密過濾膜等”中所記載之膜中,分為上下2層者中將上層的膜設置於細胞懸浮液的流入側、將下層的膜設置於上層的膜的流出側。[Examples 1 to 26 and Comparative Examples 1 to 10] [Evaluation 1] Each coarse filter membrane and each precision filter membrane produced was cut into 25 mm φ circles, and the separation substrate produced by stacking in the manner of the stacked structure described in Table 3 below was assembled on a commercially available filter support frame. Next, a polyvinyl chloride hose with an inner diameter of 3 mm and a length of 30 cm was connected to the inlet and outlet sides of the filter support frame. A syringe with a piston removed was connected to the end of the hose on the inlet side, and the syringe part was fixed with a clamp to suspend the syringe, hose, and filter support frame in the direction of the lead hammer. In addition, with the hose connected, the filter support frame is reversed up and down so that the inflow side becomes the lower side and the outflow side becomes the upper side to prevent the hose from breaking, and the clamp is fixed at a position 20 cm below the bottom of the syringe. In addition, the part of the bottom of the syringe close to the hose is fixed with a clamp and sealed, and then the cell suspension is introduced into the syringe. Then, the clamp is opened and the cell suspension is introduced into the filter so that it contacts the separation substrate. Next, after confirming that the filter liquid flows out from the outflow side of the filter support frame, the filter support frame is removed from the clamp, and the syringe, hose, and filter support frame are returned to the arrangement arranged along the hammer direction, and the outflowing filter liquid is recovered. The filter liquid is recovered in small portions with a certain amount of liquid, and the platelet recovery rate and megakaryocyte removal rate are measured for each liquid. During filtration, the liquid flow rate until the flow rate becomes half of the value at the beginning of filtration is evaluated as the filter life. In addition, the platelet recovery rate and megakaryocyte removal rate are evaluated using the average performance until the filter life. These results are shown in Table 3 below. In Table 3 below, the membrane listed in "coarse filter membrane, etc." is placed on the inflow side of the cell suspension, and the membrane listed in "precision filter membrane, etc." is placed on the outflow side of the membrane listed in "coarse filter membrane, etc.". In addition, in the membranes listed in "coarse filter membrane, etc." and "precision filter membrane, etc.", if they are divided into two layers, the upper membrane is placed on the inflow side of the cell suspension, and the lower membrane is placed on the outflow side of the upper membrane.

[表3]   粗過濾膜等 精密過濾膜等 血小板的回收率 巨核細胞的去除率 過濾壽命 種類 片數 種類 片數 (ml) 實施例1 R5 3 P1 3 93.1% 99.9% 56 實施例2 R5 6 P1 3 95.6% 99.9% 60 實施例3 R5 12 P1 3 93.8% 99.9% 67 實施例4 R5 18 P1 3 92.6% 99.9% 66 實施例5 R5 6 P1 3 92.7% 99.9% 47 R4 3 實施例6 R5 6 P1 3 92.2% 99.9% 50 R4 5 實施例7 R5 18 P1 3 91.4% 99.9% 50 R4 5 實施例8 R5 6 P3 3 90.2% 99.9% 46 實施例9 R5 6 P4 3 97.2% 99.3% 66 實施例10 R3 4 P1 3 93.1% 99.9% 52 實施例11 R6 6 P1 3 94.0% 99.9% 53 實施例12 R5 6 P1 3 91.8% 99.9% 48 R3 3 實施例13 R6 6 P1 3 94.7% 99.9% 57 R5 6 實施例14 R2 3 P1 3 90.6% 99.9% 29 實施例15 R7 6 P1 3 93.4% 99.9% 30 實施例16 R5 6 P9 3 93.2% 99.9% 46 實施例17 R5 6 P10 3 93.5% 99.9% 53 實施例18 R12 6 P1 3 92.9% 99.9% 41 實施例19 R13 6 P1 3 93.5% 99.9% 44 實施例20 R5 6 P6 3 93.0% 99.9% 28 實施例21 R5 6 P7 3 93.5% 99.9% 36 實施例22 R9 4 P1 3 90.9% 99.9% 34 實施例23 R10 4 P1 3 91.0% 99.9% 35 實施例24 R5 2 P1 3 93.0% 99.9% 24 實施例25 R5 6 P8 3 91.1% 99.9% 15 實施例26 R11 6 P1 3 90.4% 99.9% 16 比較例1 - - P1 1 95.4% 99.3% 4 比較例2 - - P1 3 92.3% 99.9% 2 比較例3 R5 6 - - 79.6% 55.6% 124 比較例4 R5 6 - - 94.6% 84.9% 88 R4 5 比較例5 P1 3 R5 6 92.0% 99.9% 2 比較例6 P1 3 R5 6 91.9% 99.9% 2 R4 5 比較例7 R5 6 P2 3 5.4% 99.9% 1 比較例8 R5 6 P5 3 95.3% 86.4% 20 比較例9 R1 4 P1 3 11.5% 99.9% 1 比較例10 R8 6 P1 3 94.8% 99.9% 2 [Table 3] Coarse filter membrane, etc. Precision filter membrane, etc. Platelet recovery rate Megakaryocyte removal rate Filter life Type Number of pieces Type Number of pieces (ml) Embodiment 1 R5 3 P1 3 93.1% 99.9% 56 Embodiment 2 R5 6 P1 3 95.6% 99.9% 60 Embodiment 3 R5 12 P1 3 93.8% 99.9% 67 Embodiment 4 R5 18 P1 3 92.6% 99.9% 66 Embodiment 5 R5 6 P1 3 92.7% 99.9% 47 R4 3 Embodiment 6 R5 6 P1 3 92.2% 99.9% 50 R4 5 Embodiment 7 R5 18 P1 3 91.4% 99.9% 50 R4 5 Embodiment 8 R5 6 P3 3 90.2% 99.9% 46 Embodiment 9 R5 6 P4 3 97.2% 99.3% 66 Embodiment 10 R3 4 P1 3 93.1% 99.9% 52 Embodiment 11 R6 6 P1 3 94.0% 99.9% 53 Embodiment 12 R5 6 P1 3 91.8% 99.9% 48 R3 3 Embodiment 13 R6 6 P1 3 94.7% 99.9% 57 R5 6 Embodiment 14 R2 3 P1 3 90.6% 99.9% 29 Embodiment 15 R7 6 P1 3 93.4% 99.9% 30 Embodiment 16 R5 6 P9 3 93.2% 99.9% 46 Embodiment 17 R5 6 P10 3 93.5% 99.9% 53 Embodiment 18 R12 6 P1 3 92.9% 99.9% 41 Embodiment 19 R13 6 P1 3 93.5% 99.9% 44 Embodiment 20 R5 6 P6 3 93.0% 99.9% 28 Embodiment 21 R5 6 P7 3 93.5% 99.9% 36 Embodiment 22 R9 4 P1 3 90.9% 99.9% 34 Embodiment 23 R10 4 P1 3 91.0% 99.9% 35 Embodiment 24 R5 2 P1 3 93.0% 99.9% twenty four Embodiment 25 R5 6 P8 3 91.1% 99.9% 15 Embodiment 26 R11 6 P1 3 90.4% 99.9% 16 Comparison Example 1 - - P1 1 95.4% 99.3% 4 Comparison Example 2 - - P1 3 92.3% 99.9% 2 Comparison Example 3 R5 6 - - 79.6% 55.6% 124 Comparison Example 4 R5 6 - - 94.6% 84.9% 88 R4 5 Comparison Example 5 P1 3 R5 6 92.0% 99.9% 2 Comparative Example 6 P1 3 R5 6 91.9% 99.9% 2 R4 5 Comparison Example 7 R5 6 P2 3 5.4% 99.9% 1 Comparative Example 8 R5 6 P5 3 95.3% 86.4% 20 Comparative Example 9 R1 4 P1 3 11.5% 99.9% 1 Comparative Example 10 R8 6 P1 3 94.8% 99.9% 2

從上述表3所示之結果可知,僅設置有精密過濾膜之分離基材的巨核細胞的去除率及血小板的回收率均高,但是過濾壽命短(比較例1及2)。 又,可知僅設置有粗過濾膜之分離基材的巨核細胞的去除率降低(比較例3及4)。 又,可知從細胞懸浮液的流入側依序配置有精密過濾層及粗過濾層之分離基材的過濾壽命短(比較例5及6)。 又,可知作為精密過濾膜使用平均孔徑小於2.0μm的過濾膜之情況下,血小板的回收率變低且過濾壽命亦短(比較例7)。 又,可知作為精密過濾膜使用平均孔徑超過20μm的過濾膜之情況下,巨核細胞的去除率變低且過濾壽命亦短(比較例8)。 又,可知作為粗過濾膜使用平均孔徑小於5.0μm的過濾膜之情況下,血小板的回收率變低且過濾壽命亦短(比較例9)。 又,可知作為粗過濾膜使用平均孔徑超過30μm的過濾膜之情況下,過濾壽命短(比較例10)。 相對於此,可知從細胞懸浮液的流入側依序配置有包含粗過濾膜X之粗過濾層及包含精密過濾膜Y之精密過濾層之分離基材的巨核細胞的去除率及血小板的回收率均高並且過濾壽命長(實施例1~26)。 又,從實施例2、11及15的對比可知,若粗過濾膜X為滿足上述式(1)之膜,則分離基材的過濾壽命變得更長。 又,從實施例10、22及23的對比可知,若粗過濾膜X的孔隙率為40%以上且90%以下,則血小板的回收率變得更高且分離基材的過濾壽命變得更長。 又,從實施例2、16、17、20及21的對比可知,若精密過濾膜Y的孔隙率為40%以上且90%以下,則血小板的回收率變得更高且分離基材的過濾壽命變得更長。 又,從實施例1及24的對比可知,若粗過濾層包含3片以上的粗過濾膜,則分離基材的過濾壽命變得更長。From the results shown in Table 3 above, it can be seen that the separation substrate provided with only a fine filter membrane has high megakaryocyte removal rate and platelet recovery rate, but the filtration life is short (Comparison Examples 1 and 2). In addition, it can be seen that the separation substrate provided with only a coarse filter membrane has a lower megakaryocyte removal rate (Comparison Examples 3 and 4). In addition, it can be seen that the separation substrate provided with a fine filter layer and a coarse filter layer in order from the inflow side of the cell suspension has a short filtration life (Comparison Examples 5 and 6). In addition, it can be seen that when a filter membrane with an average pore size of less than 2.0μm is used as a precision filter membrane, the platelet recovery rate becomes low and the filter life is also short (Comparative Example 7). In addition, it can be seen that when a filter membrane with an average pore size of more than 20μm is used as a precision filter membrane, the megakaryocyte removal rate becomes low and the filter life is also short (Comparative Example 8). In addition, it can be seen that when a filter membrane with an average pore size of less than 5.0μm is used as a coarse filter membrane, the platelet recovery rate becomes low and the filter life is also short (Comparative Example 9). In addition, it can be seen that when a filter membrane with an average pore size of more than 30 μm is used as a coarse filter membrane, the filtration life is short (Comparative Example 10). In contrast, it can be seen that the separation substrate in which a coarse filter layer including a coarse filter membrane X and a fine filter layer including a fine filter membrane Y are arranged in order from the inflow side of the cell suspension has a high megakaryocyte removal rate and a platelet recovery rate and a long filtration life (Examples 1 to 26). In addition, from the comparison of Examples 2, 11 and 15, it can be seen that if the coarse filter membrane X is a membrane that satisfies the above formula (1), the filtration life of the separation substrate becomes longer. Furthermore, from the comparison of Examples 10, 22, and 23, it can be seen that if the porosity of the coarse filter membrane X is 40% or more and 90% or less, the recovery rate of platelets becomes higher and the filtration life of the separation substrate becomes longer. Furthermore, from the comparison of Examples 2, 16, 17, 20, and 21, it can be seen that if the porosity of the precision filter membrane Y is 40% or more and 90% or less, the recovery rate of platelets becomes higher and the filtration life of the separation substrate becomes longer. Furthermore, from the comparison of Examples 1 and 24, it can be seen that if the coarse filter layer includes 3 or more coarse filter membranes, the filtration life of the separation substrate becomes longer.

[實施例2、3及5~7] 〔評價2〕 參閱非專利文獻〔Life Support and Anesthesia、vol.8、no.11、2001-11,p.1010-p.1013〕,製作過濾器外殼,將在實施例2、3及5~7的評價1中製作之積層體(分離基材)切成圓形組裝於過濾器外殼內。 將分離基材組裝於過濾器外殼時,將填充劑封入過濾器外殼內部空間中的分離基材外周部分,將分離基材固定於過濾器外殼內。 接著,將與評價1相同的細胞懸浮液移液到輸液袋中,連結於放大過濾器的流入側。此時,使用軟管夾具,以免輸液袋內的細胞懸浮液流入放大過濾器。 接著,從輸液袋的上部懸掛於支架上,開放軟管夾具,藉此進行了細胞懸浮液的過濾。 關於濾液的回收及分離性、過濾壽命的評價,以與使用市售的過濾器支撐架之評價相同的方式進行了實施。將結果示於下述表4中。[Examples 2, 3 and 5 to 7] [Evaluation 2] Referring to the non-patent literature [Life Support and Anesthesia, vol.8, no.11, 2001-11, p.1010-p.1013], a filter housing is prepared, and the laminate (separation substrate) prepared in Evaluation 1 of Examples 2, 3 and 5 to 7 is cut into a circular shape and assembled in the filter housing. When assembling the separation substrate in the filter housing, a filler is sealed in the outer peripheral portion of the separation substrate in the internal space of the filter housing, and the separation substrate is fixed in the filter housing. Next, the same cell suspension as in Evaluation 1 was transferred to the infusion bag and connected to the inflow side of the amplification filter. At this time, a hose clamp was used to prevent the cell suspension in the infusion bag from flowing into the amplification filter. Next, the infusion bag was hung on the bracket from the top, and the hose clamp was opened to filter the cell suspension. The evaluation of the recovery, separation and filtration life of the filtrate was carried out in the same manner as the evaluation using a commercially available filter support. The results are shown in Table 4 below.

[表4]   粗過濾膜等 精密過濾膜等 血小板的回收率 巨核細胞的去除率 過濾壽命 種類 片數 種類 片數 (ml) 實施例2 R5 6 P1 3 96.5% 99.9% 730 實施例3 R5 12 P1 3 95.2% 99.9% 780 實施例5 R5 6 P1 3 94.2% 99.9% 540 R4 3 實施例6 R5 6 P1 3 94.1% 99.9% 600 R4 5 實施例7 R5 18 P1 3 93.0% 99.9% 610 R4 5 [Table 4] Coarse filter membrane, etc. Precision filter membrane, etc. Platelet recovery rate Megakaryocyte removal rate Filter life Type Number of pieces Type Number of pieces (ml) Embodiment 2 R5 6 P1 3 96.5% 99.9% 730 Embodiment 3 R5 12 P1 3 95.2% 99.9% 780 Embodiment 5 R5 6 P1 3 94.2% 99.9% 540 R4 3 Embodiment 6 R5 6 P1 3 94.1% 99.9% 600 R4 5 Embodiment 7 R5 18 P1 3 93.0% 99.9% 610 R4 5

從上述表4所示之結果可知,實施例2、3及5~7中,經放大之評價中,巨核細胞的去除率及血小板的回收率均高並且過濾壽命長。From the results shown in Table 4 above, it can be seen that in Examples 2, 3, and 5 to 7, the megakaryocyte removal rate and platelet recovery rate were high and the filtration life was long in the enlarged evaluation.

無。without.

Claims (12)

一種分離基材,其係由用於從包含巨核細胞及血小板之細胞懸浮液分離血小板之多孔體構成,前述分離基材中,前述分離基材具有從前述細胞懸浮液的流入側依序配置有粗過濾層及精密過濾層之區域,前述粗過濾層包含1片以上的粗過濾膜,前述精密過濾層包含1片以上的精密過濾膜,前述粗過濾膜中的至少1片為藉由半乾法測量之平均孔徑成為5.0μm以上且30.0μm以下並且細孔直徑分布的峰值成為小於30%之粗過濾膜X,前述精密過濾膜中的至少1片為藉由半乾法測量之平均孔徑成為2.0μm以上且20.0μm以下並且細孔直徑分布的峰值成為30%以上之精密過濾膜Y,其中前述粗過濾膜X為滿足下述式(1)之膜,150
Figure 110100191-A0305-02-0027-1
平均孔徑(μm)的數值×厚度(μm)的數值
Figure 110100191-A0305-02-0027-2
1500 (1)。
A separation substrate is composed of a porous body for separating platelets from a cell suspension containing megakaryocytes and platelets. The separation substrate has a region in which a coarse filter layer and a fine filter layer are sequentially arranged from the inflow side of the cell suspension. The coarse filter layer includes one or more coarse filter membranes, and the fine filter layer includes one or more fine filter membranes. At least one of the coarse filter membranes is formed by a semi-dry method. A coarse filter membrane X having an average pore size of 5.0 μm or more and 30.0 μm or less and a peak value of a pore size distribution of less than 30%, wherein at least one of the above-mentioned precision filter membranes is a precision filter membrane Y having an average pore size of 2.0 μm or more and 20.0 μm or less and a peak value of a pore size distribution of more than 30%, wherein the above-mentioned coarse filter membrane X is a membrane satisfying the following formula (1), 150
Figure 110100191-A0305-02-0027-1
Average pore size (μm) × thickness (μm)
Figure 110100191-A0305-02-0027-2
1500 (1).
如請求項1所述之分離基材,其中前述精密過濾膜Y的孔隙率為40%以上且90%以下。 The separation substrate as described in claim 1, wherein the porosity of the aforementioned precision filter membrane Y is greater than 40% and less than 90%. 如請求項1所述之分離基材,其中前述粗過濾膜X的孔隙率為40%以上且90%以下。 The separation substrate as described in claim 1, wherein the porosity of the aforementioned coarse filter membrane X is greater than 40% and less than 90%. 如請求項1所述之分離基材,其中前述粗過濾層包含3片以上的粗過濾膜。 The separation substrate as described in claim 1, wherein the aforementioned coarse filter layer comprises more than 3 coarse filter membranes. 如請求項1所述之分離基材,其中前述粗過濾層中所包含之所有粗過濾膜及前述精密過濾層中所包含之所有精密過濾膜為臨界潤濕表面張力為72mN/m以上的膜。 The separation substrate as described in claim 1, wherein all the coarse filter membranes contained in the aforementioned coarse filter layer and all the fine filter membranes contained in the aforementioned fine filter layer are membranes with a critical wetting surface tension of 72 mN/m or more. 如請求項1所述之分離基材,其中前述多孔體為不織布。 The separation substrate as described in claim 1, wherein the aforementioned porous body is a non-woven fabric. 如請求項6所述之分離基材,其中前述不織布包含選自包括纖維素樹脂及聚烯烴樹脂之群組中之至少1種樹脂。 The separation substrate as described in claim 6, wherein the nonwoven fabric comprises at least one resin selected from the group consisting of cellulose resins and polyolefin resins. 如請求項7所述之分離基材,其中前述纖維素樹脂為纖維素醯化物或纖維素。 The separation substrate as described in claim 7, wherein the aforementioned cellulose resin is cellulose acylate or cellulose. 如請求項7所述之分離基材,其中前述聚烯烴樹脂為聚丙烯。 The separation substrate as described in claim 7, wherein the aforementioned polyolefin resin is polypropylene. 如請求項9所述之分離基材,其中前述聚丙烯為經親水化處理之聚丙烯。 The separation substrate as described in claim 9, wherein the aforementioned polypropylene is hydrophilized polypropylene. 一種細胞分離過濾器,其具備:容器,配置有第1通液口及第2通液口;及過濾材料,填充於前述第1通液口及前述第2通液口之間,前述細胞分離過濾器中,前述過濾材料係如請求項1至請求項10之任一項所述之分離基材。 A cell separation filter comprises: a container having a first liquid port and a second liquid port; and a filter material filled between the first liquid port and the second liquid port. In the cell separation filter, the filter material is a separation substrate as described in any one of claim 1 to claim 10. 一種血小板之製造方法,其具有:接觸步驟,其為使至少包含巨核細胞之培養液與如請求項1至請求項10之任一項所述之分離基材接觸之步驟;培養步驟,在前述接觸步驟之前及之後的至少一者中,培養巨核細胞而產生血小板;及回收步驟,在前述接觸步驟及前述培養步驟之後,回收含有所產生之血小板之培養液。 A method for producing platelets, comprising: a contacting step, which is a step of bringing a culture medium containing at least megakaryocytes into contact with a separation substrate as described in any one of claim 1 to claim 10; a culturing step, in at least one of before and after the contacting step, culturing megakaryocytes to produce platelets; and a recovery step, in which after the contacting step and the culturing step, the culture medium containing the produced platelets is recovered.
TW110100191A 2020-01-27 2021-01-05 Separation base, cell separation filter, and method of preparing platelet TWI856228B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-011123 2020-01-27
JP2020011123 2020-01-27

Publications (2)

Publication Number Publication Date
TW202130802A TW202130802A (en) 2021-08-16
TWI856228B true TWI856228B (en) 2024-09-21

Family

ID=77078973

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110100191A TWI856228B (en) 2020-01-27 2021-01-05 Separation base, cell separation filter, and method of preparing platelet

Country Status (3)

Country Link
JP (1) JP7454596B2 (en)
TW (1) TWI856228B (en)
WO (1) WO2021153093A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117757628B (en) * 2024-02-22 2024-09-27 深圳市合川医疗科技有限公司 A platelet in vitro culture device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201900228A (en) * 2017-05-12 2019-01-01 日商富士軟片股份有限公司 Separation substrate, cell separation filter, and method for producing platelets
TW201900866A (en) * 2017-05-12 2019-01-01 日商富士軟片股份有限公司 Separation substrate, cell separation filter, and method for producing platelets

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201900228A (en) * 2017-05-12 2019-01-01 日商富士軟片股份有限公司 Separation substrate, cell separation filter, and method for producing platelets
TW201900866A (en) * 2017-05-12 2019-01-01 日商富士軟片股份有限公司 Separation substrate, cell separation filter, and method for producing platelets

Also Published As

Publication number Publication date
TW202130802A (en) 2021-08-16
JPWO2021153093A1 (en) 2021-08-05
WO2021153093A1 (en) 2021-08-05
JP7454596B2 (en) 2024-03-22

Similar Documents

Publication Publication Date Title
JP4863714B2 (en) Composite porous membrane and method for producing the same
JP3941838B2 (en) Leukocyte removal filter material
US8535943B2 (en) Blood platelet induction method
JPWO1997023266A1 (en) Leukocyte removal filter material
TWI780148B (en) Separation base, cell separation filter, and method of preparing platelet
US10478537B2 (en) Cell separation filter material and filter obtained by layering same
TWI835989B (en) Cell separation filter, filtration device,and method for producing cell separation filter
JP2012183237A (en) New leukocyte removal filter
WO2018194061A1 (en) Filter container for separating cells and filter device for separating cells
US10265456B2 (en) Blood filter and method of manufacturing the same
TWI855992B (en) Separation base, cell separation filter, and method of preparing platelet
TWI856228B (en) Separation base, cell separation filter, and method of preparing platelet
JP4992115B2 (en) Composite membrane and manufacturing method thereof
CN105821493A (en) Method for preparing composite nanofiber, composite nanofiber prepared by method, filter layer body and mask with filter layer body
Bruil et al. Poly (ethyleneimine) modified filters for the removal of leukocytes from blood
JP4384823B2 (en) Leukocyte removal filter device and leukocyte removal method
JPWO2019004388A1 (en) Blood treatment filter and blood treatment method
JP2022018927A (en) Blood processing filter
CN111603949A (en) Nylon membrane and preparation method and application thereof
Steneker et al. BY FILTRATION